Heparin-induced thrombocytopenia: An uncommon but serious complication of heparin use in renal replacement therapy

Hemodialysis International

Volumn 10, Issue 3, 2006, Pages 235-240

  Charif, Rawya ^a,b   Davenport, Andrew ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b WEXHAM PARK HOSPITAL   (United Kingdom)

Author keywords

Hemodialysis; Heparin induced thrombocytopenia; HIT type II

Indexed keywords

DANAPAROID; HEPARIN; WARFARIN;

AGED; ANTICOAGULATION; ARTICLE; CASE REPORT; CLINICAL PROTOCOL; DRUG INFUSION; DRUG WITHDRAWAL; HEMODIALYSIS; HEPARIN INDUCED THROMBOCYTOPENIA; HOSPITAL DISCHARGE; HUMAN; KIDNEY FAILURE; LUNG EMBOLISM; MALE; PHYSICAL EXAMINATION; SYMPTOM; THROMBOCYTE COUNT; THROMBOSIS;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; HEPARIN; HUMANS; MALE; RENAL DIALYSIS; RENAL REPLACEMENT THERAPY; THROMBOCYTOPENIA;

EID: 33645327841     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2006.00101.x     Document Type: Article

References (18)

1. Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med. 1995; 332: 1330-1336.
2. Yamamoto S, Koide M, Matsuo M, et al. Heparin-induced thrombocytopenia in haemodialysis patients. Am J Kidney Dis. 1996; 28: 82-85.
3. Davenport A. The management of heparin induced thrombocytopenia during renal replacement therapy. Hemodial Int. 2001; 5: 81-85.
4. Chong BH. Heparin-induced thrombocytopenia. Br J Haematol. 1995; 89: 431-439.
5. Chong BH. Heparin-induced thrombocytopenia. J Thromb Haemost. 2003; 1: 1471-1478.
6. Cines DB, Tomaski A, Tannenbaum S. Immune endothelial-cell injury in heparin-associated thrombocytopenia. N Engl J Med. 1987; 316: 581-589.
7. Blank M, Shoenfeld Y, Tavor S, et al. Anti-platelet factor 4/heparin antibodies from patients with heparin induced thrombocytopenia provoke direct activation of microvascular endothelial cells. Int Immunol. 2002; 14: 121-129.
8. Regault V, De Maistre E, Carteaux J-P, Gruel Y, Nguyen P. Platelet activation induced by human antibodies to interleukin-8. Blood. 2003; 101: 1419-1421.
9. Hong AP, Cook DJ, Sigouin CS, Warkentin TE. Central venous catheters and upper extremity deep vein thrombosis complicating immune heparin induced thrombocytopenis. Blood. 2003; 101: 3049-3051.
10. Davenport A. Management of heparin-induced thrombocytopenia during continuous renal replacement therapy. Am J Kidney Dis. 1998; 32: E3.
11. Rice L, Attisha WK, Drexler A, Francis JL. Delayed onset-heparin induced thrombocytopenia. Ann Int Med. 2002; 136: 210-215.
12. Warkentin TE. Acute systemic reactions to intravenous heparin bolus therapy. Blood. 1992; 80 (Suppl 1): 160a.
13. Popov D, Zarrabi MH, Foda H, Graber M. Pseudopulmonary embolism: Acute respiratory distress in syndrome of heparin-induced thrombocytopenia. Am J Kidney Dis. 1997; 29: 449-452.
14. Perkins RM, Lee JD, Rutberg S, McCune DE, Cooper RH. Thrombocytopenia and acute respiratory distress associated with intravenous bolus heparin exposure. Hosp Physician. 2003; 39: 59-61.
15. Tejedor Alonso MA, Lopez Revuelta K, Garcia Bueno MJ, et al. Thrombocytopenia and anaphylaxis secondary to heparin in a haemodialysis patient. Clin Nephrol. 2005; 63: 236-240.
16. Warkentin TE, Roberts RS, Hirsch J, Kelton JG. Heparin-induced skin lesions and other unusual sequelae of the heparin-induced thrombocytopenia syndrome. Chest. 2005; 127: 1857-1861.
17. Warkentin TE, Kelton JG. A 14-year study of heparin-induced thrombocytopenia. Am J Med. 1996; 101: 502-507.
18. Warkentin TE, Greinacher A. Heparin-Induced Thrombocytopenia. 2nd Ed. Basel: Marcel Dekker Inc.; 2001.